Company President and CEO of $MIST sells 43,000 shares in insider sale

The recent insider sale of 43,000 shares by Joseph Oliveto, the President and CEO of $MIST, has sparked interest within the investment community. The sale, valued at approximately $96,750 and representing around 12.4% of Oliveto’s shares of this class of stock, was disclosed through a recent SEC filing. Following this transaction, Oliveto retains ownership of 303,721 shares of $MIST stock in this class.

Over the past six months, $MIST insiders have engaged in two trades on the open market, with both transactions being sales rather than purchases. Joseph Oliveto, in particular, has not made any purchases but has sold a total of 43,500 shares, amounting to an estimated $97,875. For those interested in monitoring insider transactions, the insider trading dashboard provided by Quiver Quantitative offers valuable insights.

In terms of hedge fund activity related to $MIST, 45 institutional investors have increased their positions in the stock, while 12 have decreased their holdings in the most recent quarter. Notable additions to $MIST stock include Adage Capital Partners GP, L.L.C., Propel Bio Management, LLC, Orbimed Advisors LLC, Morgan Stanley, and Simplify Asset Management Inc. On the other hand, Alta Fundamental Advisers LLC and BML Capital Management, LLC have removed shares from their portfolios.

Wall Street analysts have also been active in providing their perspectives on $MIST. Reports from two firms have issued buy ratings on the stock, with no sell ratings being issued. Noteworthy analyst ratings include a “Buy” rating from HC Wainwright & Co. on January 6, 2026, and an “Overweight” rating from Wells Fargo on December 16, 2025. Investors interested in tracking analyst ratings and price targets for $MIST can refer to the forecast page provided by Quiver Quantitative.

Several analysts have recently issued price targets for $MIST, with a median target of $8.0 among the three analysts who have offered their projections in the last six months. Analysts such as Brandon Folkes from HC Wainwright & Co., Mohit Bansal from Wells Fargo, and Ritu Baral from TD Cowen have all set a target price of $8.0 for $MIST.

It is essential for readers to note that the information presented in this article is not intended as financial advice. Those seeking further details or clarification should refer to the disclaimers provided by Quiver Quantitative for additional information.